Title |
Anticarcinogenic Effect of ITCs Against Prostate Cancer
|
Institution |
UNIVERSITY OF PITTSBURGH, PITTSBURGH, PA
|
Principal Investigator |
Singh, Shivendra
|
NCI Program Director |
Young Kim
|
Cancer Activity |
Nutrition (DCP)
|
Division |
DCP
|
Funded Amount |
$300,172
|
Project Dates |
07/14/2003 - 11/30/2014
|
Fiscal Year |
2013
|
Project Type |
Grant
|
Research Topics w/ Percent Relevance |
Cancer Types w/ Percent Relevance |
Cancer (100.0%)
Chemoprevention (100.0%)
|
Prostate (100.0%)
|
Research Type |
Chemoprevention
Systemic Therapies - Discovery and Development
|
Abstract |
ABSTRACT: Background and Hypothesis: Because prostate cancer is a leading cause of cancer related deaths among men in the United States, novel strategies to prevent this disease are highly desirable. During the funded period of this grant, we demonstrated that cruciferous vegetable constituent phenethyl isothiocyanate (PEITC) suppresses growth of prostate cancer cells in culture and in vivo irrespective of their androgen responsiveness or p53 status. The PEITC-mediated suppression of prostate cancer cell growth correlated with type I apoptotic cell death as well as type II autophagic death. We also found that PEITC is a potent suppressor of angiogenesis in vitro and ex vivo. The present continuation application builds upon these novel observations and proposes experiments that will not only test the efficacy of dietary PEITC administration for prevention of prostate carcinogenesis and metastasis in a transgenic mouse model of prostate cancer (TRAMP) but also fill the gaps in our knowledge concerning mechanism of its anticarcinogenic effects. We hypothesize that PEITC administration will prevent prostate carcinogenesis and metastasis in TRAMP mice by causing apoptotic and autophagic death and suppressing angiogenesis. The mechanistic hypothesis predicts that while ROS generation is a critical event in PEITC-induced apoptosis (and possibly autophagy), induction of autophagy and suppression of angiogenesis is mediated by inhibition of Akt and its downstream effectors. Specific Aims: The specific aims of the present renewal application are to: (1) determine the efficacy of dietary PEITC administration for prevention of prostate carcinogenesis in male TRAMP mice and determine markers/molecular regulators of apoptosis, autophagy, and angiogenesis in prostate/tumor tissues harvested from control and PEITC-fed TRAMP mice; (2) determine the role of ROS in apoptosis induction by PEITC using PC-3, LNCaP and PrEC cells as a model; (3) determine the mechanism of PEITC-mediated autophagy using above mentioned cells as a model; and (4) determine the efficacy of dietary PEITC administration for inhibition of angiogenesis in vivo using Matrigel plug assay and elucidate the mechanism of Akt inactivation by PEITC using PC-3 and LNCaP cells as a model. Significance: Positive outcome of the proposed preclinical studies will provide compelling rationale for initiation of clinical trials to determine efficacy of PEITC against human prostate cancer. |